Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
UBS
Farmers Insurance
Boehringer Ingelheim
Teva
Harvard Business School
Dow
Medtronic
Argus Health

Generated: May 24, 2018

DrugPatentWatch Database Preview

CENESTIN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Cenestin patents expire, and when can generic versions of Cenestin launch?

Cenestin is a drug marketed by Teva Branded Pharm and is included in one NDA.

The generic ingredient in CENESTIN is estrogens, conjugated synthetic a. There are three drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the estrogens, conjugated synthetic a profile page.
Drug patent expirations by year for CENESTIN
Synonyms for CENESTIN
16680-47-0
17-Oxoestra-1,3,5(10),7-tetraen-3-yl sodium sulfate
27540-07-4 (Parent)
3-(Sulfooxy)estra-1,3,5(10),7-tetraen-17-one Sodium Salt
3-Hydroxyestra-1,3,5(10),7-tetraen-17-one Hydrogen Sulfate Sodium Salt
7XY8FW3E68
AKOS027322958
Ayerogen
Ayerogen Crema Vaginal
Azumon
C.E.S
C13416
CCRIS 7207
CEE
CHEBI:32143
Climarest
Climatrol
Climestrone
Climopax
CO-Estro
Conest
Conestron
Conjes
Conjugated equine estrogen
Conjugated estrogenic hormones
Conjugated estrogens: sodium equilin sulfate
Conjugen
Conjutabs
D02YUT
Dagynil
DTXSID00872961
EINECS 235-199-5
EINECS 240-727-2
Emopremarin
Equigyne
Equilin 3-Sulfate Sodium Salt
Equilin sodium sulfate
Equilin, sulfate, sodium salt (6CI)
Equin
ESE (Esterified Estrogen)
Estra-1,3,5(10),7-tetraen-17-one, 3-(sulfooxy)-, sodium salt
Estra-1,3,5(10),7-tetraen-17-one, 3-hydroxy-, hydrogen sulfate sodium salt (8CI)
Estra-1,3,5(10),7-tetraen-17-one,3-(sulfooxy)-,sodium salt
Estratab
Estrifol
Estroate
Estrocon
Estrogenic substances, cojugated
Estrogens conjugated [USP]
Estrogens, Conjugated
Estrogens, conjugated [USP:JAN]
Estrogens, conjugates
Estromed
Estropan
FEM H
Femacoid
Femavit
Femest
Formatrix
Ganeake
Genisis
Glyestrin
Hyphorin
J-004475
Kestrin
LS-2303
Mannest
Menogen
Menopak-E
Menoprem Continuous
Menotab
Menotrol
Menpoz
Msmed
Neo-Menovar
Novoconestron
Oestrilin
Oestro-feminal
Oestropak morning
Ovest
Palopause
PL043155
Premaril
Premaril Plus
PREMARIN (EQUILIN)
Premarin Crema V
Premarin Creme
Premarin Vaginal Creme
Premarina
Premarose
Prempak
Presomen
Prevagin-Premaril
Primarin
Promarit
Provette Continuous
Romeda
SCHEMBL974791
Sefac
Sodestrin-H
SODIUM (1S,11S,15S)-15-METHYL-14-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-2(7),3,5,9-TETRAEN-5-YL SULFATE
sodium 17-oxoestra-1(10),2,4,7-tetraen-3-yl sulfate
Sodium equilin 3-monosulfate
Sodium equilin sulfate
Sodium estrone sulfate, mixted with sodium equilin sulfate
Srogen
Sukingpo
TAG-39
Theogen
Transannon
UNII-3ASP8Q3768 component QTTMOCOWZLSYSV-QWAPEVOJSA-M
UNII-7XY8FW3E68
UNII-8L6LAK9BTR component QTTMOCOWZLSYSV-QWAPEVOJSA-M
UNII-IU5QR144QX component QTTMOCOWZLSYSV-QWAPEVOJSA-M
UNII-JM2621P2LS component QTTMOCOWZLSYSV-QWAPEVOJSA-M
Zeste

US Patents and Regulatory Information for CENESTIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Branded Pharm CENESTIN estrogens, conjugated synthetic a TABLET;ORAL 020992-001 Jun 21, 2002 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Branded Pharm CENESTIN estrogens, conjugated synthetic a TABLET;ORAL 020992-003 Mar 24, 1999 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Branded Pharm CENESTIN estrogens, conjugated synthetic a TABLET;ORAL 020992-005 Feb 5, 2004 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Branded Pharm CENESTIN estrogens, conjugated synthetic a TABLET;ORAL 020992-002 Mar 24, 1999 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for CENESTIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teva Branded Pharm CENESTIN estrogens, conjugated synthetic a TABLET;ORAL 020992-002 Mar 24, 1999 ➤ Sign Up ➤ Sign Up
Teva Branded Pharm CENESTIN estrogens, conjugated synthetic a TABLET;ORAL 020992-001 Jun 21, 2002 ➤ Sign Up ➤ Sign Up
Teva Branded Pharm CENESTIN estrogens, conjugated synthetic a TABLET;ORAL 020992-004 Mar 13, 2000 ➤ Sign Up ➤ Sign Up
Teva Branded Pharm CENESTIN estrogens, conjugated synthetic a TABLET;ORAL 020992-003 Mar 24, 1999 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Paragraph IV (Patent) Challenges for CENESTIN
Drugname Dosage Strength RLD Submissiondate
➤ Subscribe Tablets 0.3 mg, 0.45 mg and 0.9 mg ➤ Subscribe 2009-03-19
➤ Subscribe Tablets 0.625 mg ➤ Subscribe 2009-03-02
➤ Subscribe Tablets 1.25 mg ➤ Subscribe 2008-11-03

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Merck
Moodys
Healthtrust
Chubb
Federal Trade Commission
Queensland Health
Express Scripts
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.